Alligator Bioscience rights issue subscribed ~17.1%; guarantees ~29.7%
Alligator Bioscience says its rights issue of up to 3.14B units is subscribed ~17.1% with guarantees of ~29.7% to be utilized, with initial proceeds of SEK 58.8M before costs and bridge loan repayment. Final outcome is expected 22 Sep 2026.
7%. 8M before costs and bridge loan repayment. Final outcome is expected 22 Sep 2026.